The global market for Fluoroscopy and Mobile C-arms is projected to exceed US$2.8 billion by 2024, driven by aging population and technological innovations such as enhanced images and reduced dosing.
Fluoroscopy is one of the most widely used medical diagnostic technologies worldwide. Fluoroscopy and mobile C-arm equipment is a part of medical imaging equipment industry that comprises Ultrasound imaging, Computed Tomography, MRI, PET, X-Ray, and other Patient Monitoring modalities. Unlike X-ray machines, Fluoroscopy and Mobile C-arm equipment generate real-time visuals of the body parts for assisting medical professionals in surgical procedures. These machines, therefore, are used for minimally-invasive imaging for procedures, such as the insertion of intravenous catheters, cardiac catheterization, lumbar puncture, and biopsies, besides finding application in orthopedic procedures, such as in arthrography and barium X-rays. The development of C-arms enabled two-dimensional imaging, providing surgeons with real-time visuals of internal organs during minimally invasive surgical procedures.
Technological innovations represent a major growth driver for the global fluoroscopy and mobile C-arm, with the launch of sophisticated and more cost-efficient versions, driving market adoption and penetration. The introduction of highly advanced fluoroscopy and mobile C-arms systems, which provides enhanced image resolution, along with radiation dose reduction, is also expected to trigger demand as the global economy improves. The recent launch of fluoroscopy equipment with integrated flat detectors is expected to emerge as a game changer for the fluoroscopy and mobile C-arms market, with the new equipment delivering superior quality images, free from blurring and distortions at low radiation dosage levels. The market is also witnessing active sales of second-hand refurbished equipment. The refurbished and used equipment continue to demonstrate upward needle movement as a smothered global economy nudges financially-strapped consumers to reduce expenditure and seek out pre-used equipment for their healthcare units. Customers are also leveraging digital images for other workflow and clinical enhancements. However, with consumers, on an average, expecting their diagnostic imaging equipment to serve them for as long as 10 to 15 years, widespread conversion to digital is expected to be a long drawn-out process; and even in the used digital equipment segment, lofty costs are proving to be a deterrent to buyers.
Aging population is driving the need for medical procedures, such as arthrography, cardiac catheterization, intravenous catheterization, biopsies, lumbar puncture, and orthopedic surgeries, which make use of minimally-invasive imaging instruments, such as fluoroscopy and mobile c-arms. The relatively affluent aging populace in the U.S. is demanding better standards of healthcare to extend their active lifestyle. Similarly, the sizable elderly societies in Europe and Japan, and the burgeoning senior citizen population in populous countries, such as India and China, are driving healthcare providers to expand their geriatric care infrastructure in anticipation of this increasing demand.
Europe represents the largest market worldwide, followed by the United States. The market in these regions is fairly saturated, and the majority of growth likely to come from developing markets of Asia-Pacific, Latin America, the Middle East and Africa. Asia-Pacific is forecast to witness the fastest growth with a CAGR of 5.7% over the analysis period. Large population with increasing access to healthcare and growing population of elderly is leading to growth of the market in the region.
Key players in the market include GE Healthcare, Hologic, Inc., OrthoScan, Inc., Philips Healthcare, Shimadzu Corporation, Siemens Healthineers, and Ziehm Imaging GmbH among others.